• Explore /
  • Poster
  • / Should signet-ring cell histology alter the treatment approach for clinical stage I gastric cancer?

Should signet-ring cell histology alter the treatment approach for clinical stage I gastric cancer?

Abstract Poster

Authors

null

Michael K. Turgeon

Winship Cancer Institute, Division of Surgical Oncology, Department of Surgery, Emory University, Atlanta, GA

Michael K. Turgeon , Adriana C. Gamboa , Manali Rupji , Rachel M. Lee , Jeffrey M. Switchenko , Maria C. Russell , Kenneth Cardona , David A. Kooby , Charles A. Staley , Shishir K. Maithel , Mihir M. Shah

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Esophageal and Gastric Cancer and Other GI Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Patient-Reported Outcomes and Real-World Evidence

Citation

J Clin Oncol 38, 2020 (suppl 4; abstr 321)

Abstract #

321

Poster Bd #

B18

Abstract Disclosures

Similar Posters

First Author: Kai Tsugaru

Poster

2023 ASCO Gastrointestinal Cancers Symposium

The impact of peri-operative chemotherapy on the outcomes of patients with non-metastatic cholangiocarcinoma.

The impact of peri-operative chemotherapy on the outcomes of patients with non-metastatic cholangiocarcinoma.

First Author: Firas Baidoun

First Author: Thomas W. Flaig

First Author: Silvia Stacchiotti